 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
) E9 A$ @" D* m, y, I3 E+ L- B & {: N; R: Y9 X0 @* W7 U* C
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
4 v- f7 v6 [4 r- k$ O
0 z7 w8 M) i' v* ?BY THE EDMONTON JOURNAL FEBRUARY 16, 2007
- i7 S6 ^( ?) y' ? [# t $ ~: o: o6 h0 Q, _8 @# V
/ g7 G+ c5 t5 k: f, l/ z2 s
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.6 ?9 W# P' f" b, f/ g
( z, T/ T- `! S" A O
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."- Z8 u1 H4 w* Q5 V: }1 \
8 R( D. J2 }1 H u
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.9 B$ Y; z% [7 K
' U5 i4 j7 L( g6 B" E
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
. ~% S7 X/ c* l9 p0 }. e
3 h4 c9 Z& } f: Q& e- Q8 QIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.6 d7 z' `8 E' x- \3 I `4 I1 s
7 O) ^4 ?# Z: O& {
"As a scientist, it's one of the highlights of my CAREER," Shan said.
% r1 C+ Y# I3 z2 q/ E/ X* j: ?. V- R+ m: P! s/ @
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
* y/ H5 j5 y) a8 c! }, ]3 P5 H1 K+ i5 _ n- `
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
* w/ e' K# C6 f, u9 M9 t7 x- O- w
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.3 j- @; I# l! Z n
4 i) _) Y3 s1 F& w
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
) b, _, [! W, v7 U" o
$ x# C, h! O) W6 {# P
9 j1 z1 H0 T9 E/ x& c4 Y) ^5 bhttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
* s: ? F3 M: l6 u* E8 \
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
7 k3 T, x2 O& w! G# R
发表于 2015-2-28 19:45
